Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History DRRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics DRRX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Durect Corporation

DRRX
Current price
0.67 USD +0.025 USD (+3.85%)
Last closed 0.67 USD
ISIN US2666055007
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 20 696 102 USD
Yield for 12 month -47.09 %
1Y
3Y
5Y
10Y
15Y
DRRX
21.11.2021 - 28.11.2021

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment of patients with metabolic dysfunction-associated steatohepatitis. The company also offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; PERSERIS, an injectable suspension for the treatment of schizophrenia in adults; and Methydur to treat attention deficit hyperactivity disorder. It has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. Address: 10240 Bubb Road, Cupertino, CA, United States, 95014-4166

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.00 USD

P/E Ratio

Dividend Yield

Financials DRRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures DRRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+2 031 000 USD

Last Year

+8 548 000 USD

Current Quarter

+321 000 USD

Last Quarter

-3 894 000 USD

Current Year

+1 953 000 USD

Last Year

+6 831 000 USD

Current Quarter

+321 000 USD

Last Quarter

-2 814 000 USD
EBITDA -16 645 000 USD
Operating Margin TTM -1 289.41 %
Price to Earnings
Return On Assets TTM -41.39 %
PEG Ratio -0.46
Return On Equity TTM -217.95 %
Wall Street Target Price 5.00 USD
Revenue TTM 1 856 000 USD
Book Value 0.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -35.30 %
Dividend Yield
Gross Profit TTM 1 031 000 USD
Earnings per share -0.48 USD
Diluted Eps TTM -0.48 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -264.71 %

Stock Valuation DRRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.77
Price Sales TTM 11.15
Enterprise Value EBITDA -2.48
Price Book MRQ 3.87

Technical Indicators DRRX

For 52 Weeks

0.48 USD 1.74 USD
50 Day MA 0.61 USD
Shares Short Prior Month 784 074
200 Day MA 0.88 USD
Short Ratio 5.22
Shares Short 803 920
Short Percent 2.62 %